default author photo

Yinghui Xu

Jilin University (JLU) - Cancer Center

SCHOLARLY PAPERS

1

DOWNLOADS

43

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Sintilimab Plus Autologous NK Cells as Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer Previous Treated with Platinum-Containing Chemotherapy

Number of pages: 13 Posted: 21 May 2022
Jiuwei Cui, Lin Jia, Naifei Chen, Xiao Chen, Chao Niu, Ziling Liu, Kewei Ma, Nanya Wang, Lei Yang, Yuguang Zhao, Wei Song, Jin Lu, Chen Chen, Xiaofeng Cong, Xu Wang, Yinghui Xu, Guozhen Cui, Zengguang Liu, Rongrong Chen and Wei Li
Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center and Jilin University (JLU) - Cancer Center
Downloads 43 (1,145,425)

Abstract:

Loading...

Non-small-cell lung cancer, Natural killer (NK) cells, immunotherapy, pd-1 inhibitors